在两个患有管道唾液癌的患者中进行综合全身治疗
Iván A Schwartz1, María Laura Gil2, Fernando Carrizo3
1Departamento de Clínica Oncológica, Instituto de Oncología Ángel H. Roffo, Buenos Aires, Argentina.
Medicina
|December 12, 2024
概括
带有HER2过度表达和雄激素受体 (AR) 阳性的管道癌对向疗法具有前景. 化学疗法和双重药物的联合治疗在转移病例中产生了部分反应,需要进一步调查.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 导管癌是一种唾液腺癌亚型,经常表现出雄激素受体 (AR) 和HER2的共同表达.
- 这种双重积极性为精准医学方法提供了治疗目标.
更多相关视频
07:38Radiation Treatment of Organotypic Cultures from Submandibular and Parotid Salivary Glands Models Key In Vivo Characteristics
Published on: May 17, 2019
8.1K
07:25Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research
Published on: October 13, 2023
1.9K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:27Tumor Immunotherapy
476
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
476